SOUTH SAN FRANCISCO, Calif., Jan. 12, 2025 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 43rd Annual J.P. Morgan Healthcare Conference and provided 2025 corporate guidance and program updates. 43rd Annual J.P. Morgan Healthcare ConferenceMonday, January 13th,… Continue reading IDEAYA Biosciences Announces Participation at the 43rd Annual J.P. Morgan Healthcare Conference and 2025 Corporate Guidance
Tag: Morgan
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2024 Results
FY 2024 revenue of ~$611 million and Q4 2024 revenue of ~$165 million, representing 9% growth sequentially PLEASANTON, Calif., Jan. 12, 2025 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth quarter and full year ended December 31, 2024. Preliminary,… Continue reading 10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2024 Results
Clean Technica: Is Tesla In Trouble? Was Alignment With A Trump 2.0 Presidency A Profit Gamble?003798
Sign up for daily news updates from CleanTechnica on email. Or follow us on Google News! Tesla seemed as if it was on a smooth road trip looking ahead to the next four years. CEO Elon Musk single-handedly rallied voters in November’s win for the right-wing entourage of Donald J. Trump. Sure, the allegiance came… Continue reading Clean Technica: Is Tesla In Trouble? Was Alignment With A Trump 2.0 Presidency A Profit Gamble?003798
Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference
BURLINGTON, N.C., Jan. 10, 2025 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, at 3:45 p.m. (PT). A live audio webcast of the fireside chat will be available via… Continue reading Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference
David Schilansky Appointed Chief Financial Officer of Ariceum Therapeutics
BERLIN, Jan. 10, 2025 /PRNewswire/ — Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced the appointment of David Schilansky as Chief Financial Officer with immediate effect, taking over from Rainer Sturm, who will ensure a smooth transition. David has more than 25… Continue reading David Schilansky Appointed Chief Financial Officer of Ariceum Therapeutics
AEP Secures Minority Equity Interest Investment in Ohio and Indiana & Michigan Transmission Companies
A 50/50 strategic partnership between KKR and PSP Investments agrees to acquire 19.9% non-controlling equity interest in two AEP Transcos for $2.82 billion Transaction provides highly efficient financing to support AEP’s five-year, $54 billion capital investment plan, enhance reliability for customers and strengthen balance sheet COLUMBUS, Ohio, Jan. 9, 2025 /PRNewswire/ — American Electric Power… Continue reading AEP Secures Minority Equity Interest Investment in Ohio and Indiana & Michigan Transmission Companies
DIOSynVax annonce la création d’un nouveau comité consultatif pour le développement clinique de ses vaccins antigrippaux de prochaine génération, y compris la grippe aviaire
CAMBRIDGE, Angleterre et SAN DIEGO, 9 janvier 2025 /PRNewswire/ — DIOSynVax, une biotech de stade clinique à l’avant-garde du développement de vaccins innovants et à large protection, s’appuyant sur l’innocuité démontrée par son premier essai vaccinal chez l’humain contre le coronavirus, annonce son nouveau portefeuille de vaccins prépandémiques contre la grippe aviaire, supra-saisonnière et universelle,… Continue reading DIOSynVax annonce la création d’un nouveau comité consultatif pour le développement clinique de ses vaccins antigrippaux de prochaine génération, y compris la grippe aviaire
CellFE® and Syenex Collaborate to Advance Cell Engineering with Hybrid Gene Editing Workflow
ALAMEDA, Calif., Jan. 9, 2025 /PRNewswire/ — CellFE®, a leader in non-viral gene editing technology, and Syenex, a pioneer in enveloped delivery vectors, have announced an innovative collaboration to create a hybrid workflow that seamlessly integrates non-viral and viral approaches to cell therapy engineering. This next-generation process aims to enable streamlined workflows of complex edited… Continue reading CellFE® and Syenex Collaborate to Advance Cell Engineering with Hybrid Gene Editing Workflow
HDA Accounting Group Combines with EisnerAmper
Colorado-Based Firm Exclusive to Dental Practices DENVER, Jan. 9, 2025 /PRNewswire/ — Global business advisory firm EisnerAmper announces that the partners and colleagues of HDA Accounting Group (“HDA”) are joining EisnerAmper in a combination expected to close in early 2025. Continue Reading Morgan K. Hamon, HDA Managing Partner. Founded in 2011 and based in the… Continue reading HDA Accounting Group Combines with EisnerAmper
J.P. Morgan Healthcare Conference 2025: Genomics Announces Dr Jose-Carlos Gutiérrez-Ramos as New Board Member to Accelerate Global Expansion and Life Sciences R&D Growth
Dr Jose-Carlos Gutiérrez-Ramos is the Chief Science Officer at Danaher Corporation. He has held senior drug discovery roles at Pfizer, Abbvie, and GSK. As CEO and President of Synlogic, he led the company from early drug discovery to clinical stage and public markets He brings a wealth of experience across biotechs and pharmaceutical companies, combined… Continue reading J.P. Morgan Healthcare Conference 2025: Genomics Announces Dr Jose-Carlos Gutiérrez-Ramos as New Board Member to Accelerate Global Expansion and Life Sciences R&D Growth